$HIK.L

1 story mentioning HIK.LUpdated 16m ago

Every FINWIRES story that references HIK.L, newest first.

Barclays Upgrades Hikma Pharmaceuticals to Equalweight, Boosts PT

Barclays on Monday upgraded British multinational drugmaker Hikma Pharmaceuticals (HIK.L) to equal weight from underweight and raised its price target to 17.00 pounds sterling from 13.50 pounds.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

$HIK.L

Track with the FINWIRES app suite

FolioX

Track HIK.L in your portfolio

WheelAI

Analyze HIK.L options with the wheel strategy

StockInsider

See market sentiment on HIK.L